Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000483478 | SCV000573463 | uncertain significance | not provided | 2017-02-27 | criteria provided, single submitter | clinical testing | The P379R variant of uncertain significance in the CACNB2 gene has not been published as pathogenic or benign to our knowledge. This variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution also occurs at a position that is conserved across species. Furthermore, in silico analysis predicts P379R is probably damaging to the protein structure/function. Nevertheless, the Exome aggregation Consortium has observed P379R in approximately 0.17% of alleles from individuals of Finnish background, indicating it may be a rare benign variant in this population.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. |
Labcorp Genetics |
RCV001504918 | SCV001709805 | likely benign | Brugada syndrome 4 | 2020-10-27 | criteria provided, single submitter | clinical testing |